Loading...
Uploaded by BioconLimited on Nov 23, 2011
Kiran Mazumdar-Shaw of Biocon said in an exclusive interview at the Reuters India Investment Summit 2011 that the company is in advanced discussions with potential partners for its oral insulin pill and that its Syngene IPO plans remain on track
People & Blogs
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)